Industry Collaborations > Business Development Contact
The PCPGM, working with the Partners Research,
Ventures and Licensing Business Development team,
establishes strategic alliances with industry to
support innovative research and advance the translation
of science from bench to bedside. The PCPGM
has formed alliances with the following entities:
 |
Affymetrix
is a pioneer in creating breakthrough
tools that are driving the genomic revolution.
By applying the principles of semiconductor technology
to the life sciences, Affymetrix develops and commercializes
systems that enable scientists to improve quality of life.
A press release covering the alliance between Affymetrix and Partners
HealthCare can be found
here at Affymetrix's Investor Relations website.
|
 |
HP
is a technology solutions provider to consumers,
businesses and institutions globally. The company's
offerings span IT infrastructure, personal computing
and access devices, global services and imaging and
printing for consumers, enterprises and small and medium businesses.
The official press release covering the alliance established in 2003
can be found
here in HP's Newsroom. A PDF case study on the alliance can be found
here at HP.com.
|
 |
| Agilent
provides core electronic and bio-analytical measurement tools
to advance the electronics, communications, life science research, environmental and
petrochemical industries.
|
 |
| Millennium Pharmaceuticals, Inc.
is a biopharmaceutical company focused on applying its comprehensive and integrated science
and technology platform to discover and accelerate the development
of drugs and predictive medicine products.
|
 |
| Thermo Electron
Corporation is a global technology company serving
multiple markets, including the life sciences, telecommunications, food and beverage,
chemical, and oil and gas industries, with instrumentation, information-management
software, and worldwide service for a range of applications.
|
 |
| Beckman Coulter
simplifies, automates and innovates genomics processes, enabling
scientists to more readily access genomic information with the goal of
identifying new markers of biological, diagnostic and therapeutic interest. We
provide complete solutions for gene expression analysis, SNP genotyping,
automated nucleic acid sample preparation, DNA sequencing, fragment analysis and
molecular diagnostics.
|
 |
| AutoGenomics, Inc.
developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics.
|
To learn more about Partners Business Development,
click here.
|
